Neptune Wellness Solutions (NASDAQ:NEPT) Now Covered by StockNews.com

StockNews.com assumed coverage on shares of Neptune Wellness Solutions (NASDAQ:NEPTGet Rating) (TSE:NTB) in a report released on Wednesday. The brokerage set a “sell” rating on the biotechnology company’s stock.

Separately, Zacks Investment Research cut Neptune Wellness Solutions from a “buy” rating to a “hold” rating in a research report on Wednesday, April 13th.

Shares of NASDAQ NEPT opened at $0.18 on Wednesday. The stock has a market cap of $33.63 million, a PE ratio of -0.31 and a beta of 2.05. The company has a quick ratio of 1.07, a current ratio of 1.75 and a debt-to-equity ratio of 0.12. Neptune Wellness Solutions has a 52-week low of $0.17 and a 52-week high of $1.58. The business has a 50-day moving average price of $0.26 and a 200 day moving average price of $0.37.

Neptune Wellness Solutions (NASDAQ:NEPTGet Rating) (TSE:NTB) last announced its earnings results on Thursday, February 10th. The biotechnology company reported ($0.09) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.06) by ($0.03). The firm had revenue of $14.63 million during the quarter, compared to analyst estimates of $13.64 million. Neptune Wellness Solutions had a negative net margin of 207.14% and a negative return on equity of 73.19%. Sell-side analysts anticipate that Neptune Wellness Solutions will post -0.32 earnings per share for the current year.

A number of institutional investors and hedge funds have recently bought and sold shares of the business. Goldman Sachs Group Inc. raised its stake in Neptune Wellness Solutions by 2,047.4% during the 3rd quarter. Goldman Sachs Group Inc. now owns 3,005,884 shares of the biotechnology company’s stock valued at $1,817,000 after acquiring an additional 2,865,906 shares during the last quarter. Penserra Capital Management LLC raised its stake in Neptune Wellness Solutions by 5.1% during the 4th quarter. Penserra Capital Management LLC now owns 2,526,460 shares of the biotechnology company’s stock valued at $1,035,000 after acquiring an additional 123,356 shares during the last quarter. Commonwealth Equity Services LLC raised its stake in Neptune Wellness Solutions by 9.0% during the 4th quarter. Commonwealth Equity Services LLC now owns 1,254,791 shares of the biotechnology company’s stock valued at $514,000 after acquiring an additional 103,670 shares during the last quarter. Morgan Stanley raised its stake in Neptune Wellness Solutions by 256.1% during the 3rd quarter. Morgan Stanley now owns 503,122 shares of the biotechnology company’s stock valued at $304,000 after acquiring an additional 361,853 shares during the last quarter. Finally, Renaissance Technologies LLC purchased a new stake in Neptune Wellness Solutions during the 4th quarter valued at approximately $184,000. 11.72% of the stock is owned by hedge funds and other institutional investors.

Neptune Wellness Solutions Company Profile (Get Rating)

Neptune Wellness Solutions Inc, a health and wellness products company, specializes in the extraction, purification and formulation of cannabis products, as well as other specialty ingredients, such as MaxSimil, a patented ingredient that enhances the absorption of lipid-based nutraceuticals, and various other marine and seed oils.

Read More

Receive News & Ratings for Neptune Wellness Solutions Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Neptune Wellness Solutions and related companies with MarketBeat.com's FREE daily email newsletter.